Shane Kovacs
2015 - PTC Therapeutics
In 2015, Shane Kovacs earned a total compensation of $3.4M as Executive Vice President, Chief Financial Officer and Head of Corporate Development at PTC Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $187,650 |
|---|---|
| Option Awards | $2,739,337 |
| Salary | $417,000 |
| Other | $14,000 |
| Total | $3,357,987 |
Kovacs received $2.7M in option awards, accounting for 82% of the total pay in 2015.
Kovacs also received $187.7K in non-equity incentive plan, $417K in salary and $14K in other compensation.
Rankings
In 2015, Shane Kovacs' compensation ranked 2,729th out of 13,638 executives tracked by ExecPay. In other words, Kovacs earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,729 out of 13,638 | 80th |
Division Manufacturing | 962 out of 5,190 | 82nd |
Major group Chemicals And Allied Products | 350 out of 1,854 | 81st |
Industry group Drugs | 274 out of 1,528 | 82nd |
Industry Pharmaceutical Preparations | 216 out of 1,182 | 82nd |
Source: SEC filing on April 27, 2017.
Kovacs' colleagues
We found four more compensation records of executives who worked with Shane Kovacs at PTC Therapeutics in 2015.